About 2.1 million people in the United States have diagnosed type 1 diabetes, which works out to roughly 0.6% of the population. Globally, an estimated 8.4 to 8.7 million people were living with type 1 diabetes as of 2021, representing well under 1% of the world’s population. While those numbers sound small compared to the hundreds of millions with type 2 diabetes, the condition carries serious lifelong consequences and is becoming more common.
How Type 1 Compares to Type 2 by the Numbers
Of the roughly 38 million Americans with any form of diabetes, type 1 accounts for about 5 to 10%. Type 2 diabetes makes up the vast majority. But type 1 is a fundamentally different disease: the immune system destroys the cells in the pancreas that produce insulin, leaving the body unable to regulate blood sugar on its own. People with type 1 need insulin from the day of diagnosis for the rest of their lives.
The CDC’s most recent National Diabetes Statistics Report puts the U.S. count at approximately 1.8 million adults aged 20 and older and 314,000 children and adolescents under 20. That makes type 1 one of the most common chronic autoimmune diseases in children, even though most people living with it are actually adults.
Which Countries Have the Most Cases
The United States has the highest estimated total cases of type 1 diabetes worldwide, at roughly 1.5 million (using a slightly different methodology than the CDC figure). India ranks second with about 987,000 cases, followed by China (626,000), Brazil (517,000), and the United Kingdom (341,000). These totals reflect population size as much as risk. Countries like Finland and other Nordic nations have much higher rates per capita, meaning a larger share of their population develops the condition, even though their total case counts are smaller.
Modeling published in The Lancet Diabetes & Endocrinology projects that global cases will rise to between 13.5 and 17.4 million by 2040, a 60 to 107% increase over 2021. The steepest relative growth is expected in low-income and lower-middle-income countries, where access to insulin and monitoring technology is already limited.
Most People Are Diagnosed as Adults
Type 1 diabetes is often called “juvenile diabetes,” but that label is misleading. The U.S. numbers tell the story clearly: of the 2.1 million Americans with the condition, roughly 86% are adults. While onset during childhood is common and well-recognized, a substantial number of people develop type 1 in their 20s, 30s, 40s, or even later.
This creates a real diagnostic problem. About 10% of people with type 1 diabetes are initially misclassified as having type 2, according to research published in Diabetes Research and Clinical Practice. When an adult shows up with high blood sugar, clinicians often default to a type 2 diagnosis, especially if the person isn’t particularly thin. That misdiagnosis can delay appropriate insulin treatment by months or years, leading to dangerous blood sugar swings and a higher risk of a life-threatening complication called diabetic ketoacidosis.
Genetic Risk Within Families
Type 1 diabetes has a genetic component, but it’s not as straightforward as inheriting a single gene. The overall population risk is well under 1%, while having a close family member with the condition raises it meaningfully but not dramatically.
- Father with type 1: the child’s risk is about 1 in 17 (roughly 6%).
- Mother with type 1: the child’s risk is about 1 in 25 if born before the mother turned 25, dropping to 1 in 100 if born after.
- Both parents with type 1: the risk jumps to between 1 in 10 and 1 in 4.
- Parent diagnosed before age 11: the child’s risk roughly doubles compared to later-onset cases.
These numbers highlight something important: even with a parent who has type 1, the odds still favor a child not developing it. Environmental triggers, likely viral infections and other immune system activators, play a major role alongside genetics.
Impact on Life Expectancy
A 2025 systematic review in Frontiers in Endocrinology pooled data across multiple studies and found that men with type 1 diabetes live to an average of about 65 years, while women with type 1 live to about 68. For comparison, men and women without diabetes averaged about 80 and 84 years respectively. That’s a gap of roughly 14 to 16 years.
Those averages mask a wide range of outcomes. People diagnosed in recent decades with access to modern insulin pumps, continuous glucose monitors, and newer treatment approaches are expected to fare significantly better than the historical averages suggest. The gap has been narrowing over time, and tight blood sugar management is the single biggest factor in closing it further. Cardiovascular disease and kidney damage remain the primary drivers of reduced life expectancy, both of which are closely tied to how well blood sugar is controlled over decades.
Type 2 diabetes also shortens life expectancy, but less severely: men with type 2 averaged about 74 years and women about 80. The larger impact of type 1 reflects both the earlier age of onset and the complete absence of natural insulin production.
How Type 1 Diabetes Is Identified
Diagnosis relies on blood sugar measurements. An A1C level of 6.5% or higher, or a fasting blood glucose of 126 mg/dL or above, indicates diabetes. These thresholds are the same for type 1 and type 2. Distinguishing between the two typically involves testing for autoantibodies, proteins that signal the immune system is attacking the pancreas. People with type 1 usually test positive for one or more of these markers.
Symptoms of type 1 often develop faster and more dramatically than type 2, particularly in children. Rapid weight loss, extreme thirst, frequent urination, and fatigue can appear over just a few weeks. In adults, the onset is sometimes slower, which contributes to the misdiagnosis problem. If you or your child develops these symptoms suddenly, blood sugar testing can provide a quick answer.